Scinovex
article

Inclusion Studies on oral antidiabetic drugs with α-Cyclodextrin and Hydroxypropyl α-Cyclodextrin

International journal of applied research · 2015 · Vol. 1(12) · pp. 977–983

Abstract

Pioglitazone hydrochloride and Glimepiride are antidiabetic drugs. These antidiabetic drugs are poorly soluble in water which affect bioavailability. The main objective of the study is to investigate the solubility of two drugs via complexation with α-Cyclodextrin and Hydroxypropyl α-Cyclodextrin. Inclusion complexes in liquid state were prepared for both the drugs with α-Cyclodextrin (α-CD) and Hydroxypropyl α-Cyclodextrin (HPα-CD) and characterised by UV-VIS and Fluorescence Spectroscopy. Phase solubility studies indicated the formation of 1:1 stoichiometry of inclusion complexes and solubility enhancement on complexation with α-Cyclodextrin and HP α-Cyclodextrin

Drug Solubulity and Delivery SystemsCrystallization and Solubility StudiesAnalytical Methods in PharmaceuticalsCyclodextrinGlimepirideBioavailabilityChemistrySolubilityPioglitazoneDrugInclusion compoundUltraviolet visible spectroscopyNuclear chemistry
Citations
0
FWCI
0.00
field-weighted impact
References
2
Percentile
30%
vs. same field & year
References
Cyclodextrins as pharmaceutical solubilizers
Advanced Drug Delivery Reviews · 2007 · 1,822 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Inclusion Studies on oral antidiabetic drugs with α-Cyclodextrin and Hydroxypropyl α-Cyclodextrin · Scinovex